Stanley Druckenmiller: portfolio of Duquesne Family Office

Stanley Druckenmiller manages his own wealth through the Duquesne Family Office; earlier he ran the macro fund Duquesne Capital.

Source: 13F filing with the US Securities and Exchange Commission dated May 15, 2024. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q1 2024. Go to the latest filing (Q3 2026)

3.7B USDQ1 2024
Total value of stock positions
3.7B USD
Positions
72
Share of the ten largest
58.5%

The ten largest positions Q1 2024

  1. Microsoft 12.6%▲ +2.4%
  2. Coupang Inc 10.7%▼ −2.0%
  3. Teck Resources Ltd 5.6%▼ −17.6%
  4. Vistra Corp. 4.9%▲ +10.1%
  5. Natera Inc 4.7%▲ +116.0%
  6. Nvidia 4.3%▼ −71.5%
  7. Coherent Corp. 4.1%new
  8. GE Aerospace 4.0%▲ +15.9%
  9. Woodward Inc 3.9%▲ +135.8%
  10. Seagate Technology Hldngs Pl 3.6%▼ −32.0%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 4.5B USD).
Choose a quarter (54 filings)

All positions Q1 2024

Positions Q1 2024 per 13F filing, 42 of 42
Symbol Weight Shares Reported value Change Held since
COHR Coherent Corp. 4.1% 2,525,070 153.1M USD new Q1 2024 1 quarter
Discover Finl Svcs 2.3% 645,205 84.6M USD new Q1 2024 1 quarter
KMI Kinder Morgan 1.9% 3,880,500 71.2M USD new Q1 2024 1 quarter
WAB Wabtec 1.5% 386,835 56.4M USD new Q1 2024 1 quarter
META Meta Platforms 0.8% 63,930 31.0M USD new Q1 2024 1 quarter
KEY KeyCorp 0.7% 1,657,395 26.2M USD new Q1 2024 1 quarter
C Citigroup 0.7% 400,345 25.3M USD new Q1 2024 1 quarter
Madison Square Garden Entmt 0.7% 639,800 25.1M USD new Q1 2024 1 quarter
Daktronics Inc 0.6% 2,073,444 20.7M USD new Q1 2024 1 quarter
AAPL Apple Inc. 0.5% 114,700 19.7M USD new Q1 2024 1 quarter
Cinemark Hldgs Inc 0.5% 1,078,635 19.4M USD new Q1 2024 1 quarter
PLTR Palantir Technologies 0.5% 769,965 17.7M USD new Q1 2024 1 quarter
Stellantis N.V 0.4% 588,050 16.7M USD new Q1 2024 1 quarter
COF Capital One 0.4% 108,495 16.2M USD new Q1 2024 1 quarter
IQV IQVIA 0.4% 60,360 15.3M USD new Q1 2024 1 quarter
Crinetics Pharmaceuticals In 0.4% 309,000 14.5M USD new Q1 2024 1 quarter
Bank Ozk Little Rock Ark 0.3% 234,200 10.6M USD new Q1 2024 1 quarter
Global X Fds 0.3% 193,900 10.4M USD new Q1 2024 1 quarter
Banco Macro Sa 0.3% 208,730 10.1M USD new Q1 2024 1 quarter
Barclays Plc 0.3% 1,051,355 9.9M USD new Q1 2024 1 quarter
Sana Biotechnology Inc 0.3% 984,000 9.8M USD new Q1 2024 1 quarter
RDDT Reddit 0.2% 175,000 8.6M USD new Q1 2024 1 quarter
Fusion Pharmaceuticals Inc 0.2% 399,748 8.5M USD new Q1 2024 1 quarter
Silence Therapeutics Plc 0.2% 387,400 8.4M USD new Q1 2024 1 quarter
Grupo Financiero Galicia S.A 0.2% 321,863 8.2M USD new Q1 2024 1 quarter
Cabaletta Bio Inc 0.2% 417,000 7.1M USD new Q1 2024 1 quarter
NRG NRG Energy 0.2% 96,885 6.6M USD new Q1 2024 1 quarter
Legend Biotech Corp 0.2% 114,500 6.4M USD new Q1 2024 1 quarter
Veracyte Inc 0.2% 259,944 5.8M USD new Q1 2024 1 quarter
AES AES Corporation 0.2% 314,750 5.6M USD new Q1 2024 1 quarter
Nexgen Energy Ltd 0.1% 712,000 5.5M USD new Q1 2024 1 quarter
Arcellx Inc 0.1% 74,100 5.2M USD new Q1 2024 1 quarter
Tower Semiconductor Ltd 0.1% 146,400 4.9M USD new Q1 2024 1 quarter
Bicycle Therapeutics Plc 0.1% 190,200 4.7M USD new Q1 2024 1 quarter
Liberty Global Ltd 0.1% 275,275 4.7M USD new Q1 2024 1 quarter
Liberty Global Ltd 0.1% 261,875 4.6M USD new Q1 2024 1 quarter
Moonlake Immunotherapeutics 0.1% 87,500 4.4M USD new Q1 2024 1 quarter
Tg Therapeutics Inc 0.1% 280,000 4.3M USD new Q1 2024 1 quarter
Trisalus Life Sciences Inc < 0.1% 315,955 3.1M USD new Q1 2024 1 quarter
Telecom Argentina Sa < 0.1% 143,051 1.1M USD new Q1 2024 1 quarter
Nurix Therapeutics Inc < 0.1% 44,200 650.0K USD new Q1 2024 1 quarter
ETN Eaton Corporation < 0.1% 1,090 341.0K USD new Q1 2024 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 option position, value of the underlying shares as reported 664.1M USD – not included in the weights.

The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.

  • Ishares Tr Call 664.1M USD

Breakdown by sector

  • Technology 31.0%
  • Industrials 7.7%
  • Utilities 5.4%
  • Communication Services 4.4%
  • Energy 1.9%
  • Financials 1.8%
  • Materials 1.7%
  • Health Care 1.7%
  • not in our coverage 44.3%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close